The cytotoxicity of the sesamol prodrug was significantly inhibited by 1 mM BCH (p < 0.05) (Figure 5C), confirming that the sesamol prodrug was taken up via LAT1 in melanoma SK-MEL-2. Here, SLC7A5 is linked to melanoma.